Paxlovid Price Surge Expected Amidst COVID Vaccine Demand Spike

Pfizer is expected to increase the price of its COVID-19 antiviral treatment, Paxlovid, following a 400% hike in the price of its vaccines. The current price for Paxlovid is $530 for a treatment course, but it is anticipated to rise as the drug transitions from government distribution to the commercial market. The new price has not been determined yet, but one analyst suggests it could be three to five times higher, potentially reaching $2,500 per course. The price increase raises concerns about access and healthcare costs, as it may lead to decreased demand and higher insurance premiums.